Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
Methods Mol Biol. 2024;2761:599-622. doi: 10.1007/978-1-0716-3662-6_40.
Road accidents, domestic falls, and persons associated with sports and military services exhibited the concussion or contusion type of traumatic brain injury (TBI) that resulted in chronic traumatic encephalopathy. In some instances, these complex neurological aberrations pose severe brain damage and devastating long-term neurological sequelae. Several preclinical (rat and mouse) TBI models simulate the clinical TBI endophenotypes. Moreover, many investigational neuroprotective candidates showed promising effects in these models; however, the therapeutic success of these screening candidates has been discouraging at various stages of clinical trials. Thus, a correct selection of screening model that recapitulates the clinical neurobiology and endophenotypes of concussion or contusion is essential. Herein, we summarize the advantages and caveats of different preclinical models adopted for TBI research. We suggest that an accurate selection of experimental TBI models may improve the translational viability of the investigational entity.
道路交通事故、家庭跌倒以及与运动和军事服务相关的人员发生的震荡或挫伤型创伤性脑损伤 (TBI) 导致慢性创伤性脑病。在某些情况下,这些复杂的神经异常会导致严重的脑损伤和毁灭性的长期神经后遗症。一些临床前(大鼠和小鼠)TBI 模型模拟了临床 TBI 的表型。此外,许多研究性神经保护候选药物在这些模型中显示出有希望的效果;然而,这些筛选候选药物在临床试验的各个阶段的治疗效果都令人沮丧。因此,正确选择能够重现震荡或挫伤的临床神经生物学和表型的筛选模型至关重要。在此,我们总结了用于 TBI 研究的不同临床前模型的优点和注意事项。我们建议,对实验性 TBI 模型的准确选择可能会提高研究实体的转化可行性。